deltatrials
Completed PHASE1 NCT05577637

Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo

Comparitive Study Between Uvb Phototherapy Alone and Uvb Photothearpy With Topical 0.03% Tacrolimus for Treatment of Vitiligo

Sponsor: Combined Military Hospital Abbottabad

Conditions Vitiligo
Interventions 0.03% tacrolimus twice daily was applied on group A patients with uvb phototherapy thrice daily
Updated 3 times since 2022 Last updated: Oct 14, 2022 Started: May 1, 2021 Primary completion: Nov 30, 2021 Completion: Nov 30, 2021

A PHASE1 clinical study on Vitiligo, this trial is completed. The trial is conducted by Combined Military Hospital Abbottabad and has accumulated 3 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

3 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Nov 2022 — Jul 2024 [monthly]

    Completed PHASE1

    First recorded

May 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Combined Military Hospital Abbottabad
Data source: Combined Military Hospital Abbottabad

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Abbottabad, Pakistan